The prospects and challenges of chimeric antigen receptor T cell therapy for head and neck squamous cell carcinoma.
作者信息
Liu Wei, Shen Xuemin, Ren Zhenhu, Yang Xi
机构信息
Department of Oral Mucosal Diseases.
Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Center of Head and Neck Oncology Clinical and Translational Science, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine.
出版信息
Int J Surg. 2023 Sep 1;109(9):2868-2871. doi: 10.1097/JS9.0000000000000527.
Abstract
摘要
相似文献
1
The prospects and challenges of chimeric antigen receptor T cell therapy for head and neck squamous cell carcinoma.嵌合抗原受体T细胞疗法治疗头颈部鳞状细胞癌的前景与挑战
Int J Surg. 2023 Sep 1;109(9):2868-2871. doi: 10.1097/JS9.0000000000000527.
2
[Overview and prospects of neoadjuvant immunotherapy in head and neck squamous cell carcinoma].头颈部鳞状细胞癌新辅助免疫治疗的概述与展望
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Apr 7;59(4):301-305. doi: 10.3760/cma.j.cn115330-20240129-00052.
3
Therapeutic implication of chimeric antigen receptor T-cell therapy for head and neck squamous cell carcinoma.嵌合抗原受体T细胞疗法对头颈部鳞状细胞癌的治疗意义
Int J Surg. 2023 Mar 1;109(3):230-231. doi: 10.1097/JS9.0000000000000018.
4
Simultaneous concurrent chemoradiotherapy and esophagectomy for synchronous head and neck and esophageal squamous cell carcinoma: a retrospective review.同步放化疗与食管切除术治疗同步性头颈部和食管鳞状细胞癌：一项回顾性研究。
Radiat Oncol. 2025 Jul 9;20(1):107. doi: 10.1186/s13014-025-02681-0.
5
Fluorodeoxyglucose positron emission tomography-computed tomography missed tibial metastasis in head and neck cancer: a case report and review of literature.氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描漏诊头颈部癌的胫骨转移：一例报告并文献复习
J Med Case Rep. 2025 Jun 2;19(1):263. doi: 10.1186/s13256-025-05275-2.
6
Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.儿童头颈部鳞状细胞癌的系统评价和个体患者数据分析：217例病例分析
Int J Pediatr Otorhinolaryngol. 2017 Jan;92:75-81. doi: 10.1016/j.ijporl.2016.11.005. Epub 2016 Nov 12.
7
Postoperative adjuvant chemoradiotherapy versus postoperative adjuvant radiotherapy for head and neck squamous cell carcinoma with adverse pathology: a systematic review and meta-analysis.头颈部鳞状细胞癌伴不良病理特征患者术后辅助放化疗与术后辅助放疗的比较：一项系统评价和荟萃分析
Braz J Otorhinolaryngol. 2025 Jan-Feb;91(1):101516. doi: 10.1016/j.bjorl.2024.101516. Epub 2024 Oct 4.
8
MHC class I upregulation contributes to the therapeutic response to radiotherapy in combination with anti-PD-L1/anti-TGF-β in squamous cell carcinomas with enhanced CD8 T cell memory-driven response.在具有增强的CD8 T细胞记忆驱动反应的鳞状细胞癌中，MHC I类分子上调有助于放疗联合抗PD-L1/抗TGF-β治疗反应。
Cancer Lett. 2025 Jan 1;608:217347. doi: 10.1016/j.canlet.2024.217347. Epub 2024 Nov 22.
9
Advances and residual knowledge gaps in the neck management of head and neck squamous cell carcinoma patients with advanced nodal disease undergoing definitive (chemo)radiotherapy for their primary.对于患有晚期淋巴结疾病的头颈部鳞状细胞癌患者，在对其原发灶进行根治性（化疗）放疗时，颈部处理方面的进展及尚存的知识空白
Strahlenther Onkol. 2024 Jul;200(7):553-567. doi: 10.1007/s00066-024-02228-4. Epub 2024 Apr 10.
10
Update: Immunotherapeutic Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma.最新进展：人乳头瘤病毒相关头颈部鳞状细胞癌的免疫治疗策略
Viruses. 2025 May 16;17(5):712. doi: 10.3390/v17050712.
Zotero 插件